N@N

Michael Ulz Reiterated (ALNY) at Hold and Held Target at $210 on, Aug 4th, 2023

Michael Ulz of Morgan Stanley, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $210 on, Aug 4th, 2023.

Michael has made no other calls on ALNY in the last 4 months.

There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $200 on, Thursday, July 13th, 2023
• David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023

These are the ratings of the 2 analyists that currently disagree with Michael

---

• Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $405 on, Tuesday, July 25th, 2023
• Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023

Contributing Sources

---